The Medicines and Healthcare products Regulatory Agency (MHRA) issued a precautionary drug alert for two batches of Menjugate Kit (a meningitis vaccine made by Novartis) from GP surgeries, with a total of 17,000 doses.
There is currently no evidence of any risk to UK children, and there have been no reports of any infections following vaccination.
The two batches sent to the UK passed all the normal tests, including a sterility test, to ensure the safety, quality and effectiveness of the product before leaving the manufacturing site in Italy and travelling by road to the UK.
Individual GP practices that received vaccine from these batches have been contacted by the Department of Health to recall them.
